182 related articles for article (PubMed ID: 12814654)
1. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.
Mele R; Gomez Morales MA; Tosini F; Pozio E
Int J Parasitol; 2003 Jul; 33(7):757-64. PubMed ID: 12814654
[TBL] [Abstract][Full Text] [Related]
2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
3. The loading of labelled antibody-engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum.
Bondioli L; Ludovisi A; Tosi G; Ruozi B; Forni F; Pozio E; Vandelli MA; Gómez-Morales MA
Parasitology; 2011 Sep; 138(11):1384-91. PubMed ID: 21819637
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
Hommer V; Eichholz J; Petry F
J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
[TBL] [Abstract][Full Text] [Related]
7. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
8. Resolution of AIDS associated cryptosporidiosis after treatment with indinavir.
Grube H; Ramratnam B; Ley C; Flanigan TP
Am J Gastroenterol; 1997 Apr; 92(4):726. PubMed ID: 9128352
[No Abstract] [Full Text] [Related]
9. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
10. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of radix sophorae flavescentis mixture on intestinal mucosa in mice infected with Cryptosporidium parvum].
Ji R; Cui W; Liang RW; Guan ZY; Li RF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):275-9. PubMed ID: 24812877
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
13. Comment on: effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
Dugue GA
J Antimicrob Chemother; 2004 Feb; 53(2):403; author reply 403. PubMed ID: 14729752
[No Abstract] [Full Text] [Related]
14. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
Rasmussen KR; Healey MC; Cheng L; Yang S
J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
[TBL] [Abstract][Full Text] [Related]
15. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cryptosporidiosis in immunocompromised hosts.
Zardi EM; Picardi A; Afeltra A
Chemotherapy; 2005 Jul; 51(4):193-6. PubMed ID: 16006765
[TBL] [Abstract][Full Text] [Related]
17. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
18. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum.
Verdon R; Keusch GT; Tzipori S; Grubman SA; Jefferson DM; Ward HD
J Infect Dis; 1997 May; 175(5):1268-72. PubMed ID: 9129102
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
Huang K; Yang S
Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
